GMHBA Bowel Cancer Risk Identification program

Many people incorrectly assume that bowel cancer predominately has a genetic history. More than 75% of people who develop bowel cancer do not have a family history of the disease. Both women and men are at risk of developing the disease, which affects 1 in 18 men and 1 in 26 women in Australia before the age of 75.

This is one of the highest rates of bowel cancer in the world; however with early detection around 90% of cases can be treated effectively. As early diagnosis improves treatment outcomes, we remind members that GMHBA has introduced the GMHBA Bowel Cancer Risk Identification program enabling you to access an InSure Faecal Occult Blood Test (FOBT) kit.

The kit is a quick, easy, non-invasive and painless test that is undertaken in the privacy of your own home. It simply requires brushing stools with the brush supplied, onto the test indicators and posting them in the reply paid envelope for analysis.

Of the 5,628 GMHBA members who have already purchased the FOBT test, 320 returned a positive result. This may have saved them from major surgery or even saved their lives.

If eligible, you can access your Connect Rewards benefit entitlement 100% of the cost limited to one kit per person each 2 years or you can pay by cash, credit card or cheque. This offer is only available to hospital and combined hospital and extras cover policy holders.

To order your kit you can download an order form or contact GMHBA.

For more information on bowel health, visit bowelcanceraustralia.org or call (02) 9923 8269